GLORIA NARDELLA: Open Payments
NPI 1093101149 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 102 payments from 16 companies in 2025. Trend: 2023 $1,425 · 2024 $1,100 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $595 |
| AstraZeneca Pharmaceuticals LP | 10 | $398 |
| Ardelyx, Inc. | 8 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Braeburn Inc. | 5 | $97 |
| ANI Pharmaceuticals, Inc. | 2 | $58 |
| Indivior Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
Products named: VRAYLAR, AIRSUPRA, BREZTRI, IBSRELA, CAPLYTA, BRIXADI, UBRELVY, PURIFIED CORTROPHIN GEL.
Industry payments across CT — which companies pay providers there.
